XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Details) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Sep. 30, 2022
Dec. 31, 2022
Stockholders' Equity (Details) [Line Items]        
Total unrecognized compensation expense $ 368,055      
Weighted average period 3 years 7 days      
Aggregate intrinsic value of stock options, outstanding $ 59,506 $ 118,415    
Aggregate intrinsic value of stock options, exercisable $ 44,744 88,040    
Purchase an aggregate of common stock (in Shares) 24,000      
Exercise price of common stock (in Dollars per share) $ 1.94      
Purchase an aggregate of shares to common stock (in Shares) 25,000      
Exercise price (in Dollars per share) $ 1.94      
Aggregate fair value of options granted $ 90,380 $ 636,957    
Common stock outstanding $ 1,750,000      
Common stock, treasury shares (in Shares) 641,963     636,771
Repurchased shares of common stock     $ 5,192  
Purchase price per share (in Dollars per share)     $ 1.39  
2011 Plan [Member]        
Stockholders' Equity (Details) [Line Items]        
Number of shares issued under plan (in Shares) 31,548      
2016 Plan [Member]        
Stockholders' Equity (Details) [Line Items]        
Number of shares issued under plan (in Shares) 1,300,000      
Percentage of common stock delivered pursuant to incentive stock options 100.00%      
Number of stock available for future issuance (in Shares) 762,336